Navigation Links
Hospira Reports Third-Quarter 2009 Results
Date:10/27/2009

(24.9) D (20.5) D 21.5 % Stock-based compensation (8.8) (8.7) 1.1 % ---- ---- Income from operations 161.5 132.7 21.7 % Interest expense and other expense (income), net (25.2) (25.2) 0.0 % ------ ------ Income before income taxes $136.3 $107.5 26.8 % ====== ====== Included in the reported Income before income taxes above, are the following charges: A -- Americas Project Fuel $22.2 $ - Facilities Optimization 4.8 8.2 Amortization of Mayne Pharma intangible assets 3.8 4.8 Integration-related - 0.8 ------ ------ Total Americas 30.8 13.8 B -- Europe, Middle East & Africa Project Fuel 0.7 - Amortization of Mayne Pharma intangible assets 5.5 5.8 Integration-related - 0.7 ------ ------ Total Europe, Middle East & Africa 6.2 6.5 C -- Asia Pacific Project Fuel 0.6 - Amortization of Mayne Pharma intangible assets 4.2 4.6 Integration-related - 2.9 ------ ------ Total Asia Pacific
'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Dec. 4 Hospira, Inc. (NYSE: HSP ... company, today announced the launch of its next-generation 50 ... medications and solutions, and now offers a complete size ... environmentally responsible VisIV product. The launch of the 50 ...
(Date:12/4/2009)... Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary ... the initial development and successful testing of a novel ... believes this proprietary optical engine design raises the bar ... designs for swept source OCT light sources. This ...
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 1Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 2Antidepressant Use in U S Has Almost Doubled 53537 1Antidepressant Use in U S Has Almost Doubled 53537 2Antidepressant Use in U S Has Almost Doubled 53537 3Boston Scientific to Participate in BMO Capital Markets Health Care Conference 53533 1
(Date:12/5/2009)... three-drug combination has shown in a phase 1/2 ... in the treatment of patients newly diagnosed with multiple ... marrow, say researchers from Dana-Farber Cancer Institute. , Partial ... 66 patients treated with the drug combination in the ... partial response rate" in the phase 2 population, reports ...
(Date:12/5/2009)... December 5 The first Football,for Hope Centre ... opened its doors,today (5 December 2009). FIFA President ... Helen Zille, 2010 FIFA World Cup Organising Committee,South ... Association,President Kirsten Nematandani and Executive Mayor of the ...
(Date:12/5/2009)... eliminate triggers, experts advise , , SATURDAY, Dec. 5 (HealthDay ... and asthma can have bad reactions to certain holiday ... sneezing and wheezing, according to the American College of ... allergic to live evergreens may choose to decorate with ...
(Date:12/5/2009)... AVIVA today announced the launch of International Solutions, an innovative new ... of its UK equivalent. In addition to offering customers the flexibility ... their needs and budgets, International Solutions enables customers to tailor their ... , ...
(Date:12/4/2009)... Medical Systems (NYSE: VAR ) announced today that ... Meeting of Stockholders for February 11, 2010 with a record ... at the Crowne Plaza Cabana Hotel, 4290 El Camino Real, ... will be webcast by Thomson Financial and can be accessed ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
... No it is the final awakening' - Walter ... December 2006, the former president of Iraq, Saddam Hussein, was sent ... point to the fact that he slaughtered 148 fellow countrymen, who ... was, liberally put to use in all societies to wipe out ...
... compound derived from the bark of a tree could help prevent ... study.// ,The new molecule tazopsine was isolated by ... portal SciDev Net. ,Madagascar is an island nation ... is the fourth largest island in the world and is home ...
... surveying mercury contamination in fish and birds in the ... "hotspots" where concentrations// of the element exceed those established ... and Canadian research team focused on levels of the ... it also took into account contamination in other fish, ...
... always backed moderate detox diets which help in maintaining weight ... that detox kits comprising of herbal// laxatives and diuretics are ... to detox, experts say, is to avoid alcohol as a ... also recommend consumption of fruits and vegetables to pump the ...
... stomach like diarrhoea, food poisoning and indigestion formed the ... season. NHS Direct is// a telephone and internet health ... 47. ,Stomach ache, tooth ache and coughs ... festive period. ,NHS Direct got more than ...
... Levels of uric acid might have a say in whether ... , ,The study published in the January issue ... researchers, looked at 96 community-dwelling adults aged 60 to 92 ... in the high-normal range, defined as 5.8 to 7.6 milligrams ...
Other Medicine News:Health News:'Hooded Horror': Death by Hanging 2Health News:'Hooded Horror': Death by Hanging 3Health News:Mercury Contamination (Hotspots) Identified 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: